This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe
4 - 6 June, 2024
Excel London Platinum Suite

Jeanette Leusen, PhD
Professor Antibody Therapy at University Medical Center Utrecht


Jeanette Leusen received her PhD in 1995 at the University of Amsterdam (UvA), The Netherlands, and is now PI of the Immunotherapy research group (15 FTE) of the Center for Translational Immunology of the University Medical Center Utrecht. In the last 20 years Dr Leusen investigated FcR biology and the potential of IgA as a therapeutic antibody. She has co-authored about 110 peer-reviewed papers and is lead inventor on 5 patents concerning IgA. Since 2012 she is also head of the UMAB facility for antibody generation, and in 2018 she founded the spin-off company TigaTx, that is dedicated to proceed with engineered IgA towards the clinic.

Agenda Sessions

  • Engineering of IgA to Activate Neutrophils Against Cancer